This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Washington. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Jason Gilmore: Innovator in Influenza Treatment
Introduction
Jason Gilmore is an accomplished inventor based in Seattle, Washington. He has made significant contributions to the field of virology, particularly in the development of treatments for influenza. His innovative work has the potential to impact public health positively.
Latest Patents
Jason holds a patent for "De novo designed hemagglutinin binding proteins." This patent discloses polypeptides that bind to viral hemagglutinin, along with methods for their use in treating or limiting influenza infection and diagnosing influenza infection. This invention represents a crucial advancement in the fight against influenza.
Career Highlights
Jason is affiliated with the University of Washington, where he conducts research and develops innovative solutions to combat viral infections. His work is characterized by a commitment to scientific excellence and a focus on practical applications that can benefit society.
Collaborations
Jason collaborates with notable researchers, including David Baker and Aaron Arthur Chevalier. These partnerships enhance the scope and impact of his research, fostering an environment of innovation and discovery.
Conclusion
Jason Gilmore's contributions to the field of influenza treatment through his patented innovations exemplify the importance of research and collaboration in addressing public health challenges. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile